Intrastromal Injections in the Management of Infectious Keratitis
Pharmaceutics · 29.03.2023 · 15 (4) · 1091
DOI: 10.3390/pharmaceutics15041091 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 29.03.2023. Verfasst von Mihail Zemba und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University of Medicine and Pharmacy "Carol Davila", 050474 Bucharest, Romania. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Infectious keratitis is a major global cause of vision loss and blindness. Prompt diagnosis and targeted antibiotic treatment are crucial for managing the condition. Topical antimicrobials are the most effective therapy for bacterial keratitis, but they can lead to unsatisfactory results due to ocular perforation, scarring, and melting. Intrastromal injection is a newer technique for delivering antimicrobials directly to the site of infection and has been successful in treating severe, treatment-resistant infectious keratitis, especially when surgery is not recommended. In cases where deep stromal disease is resistant to topical treatment, intrastromal antimicrobial injections may be necessary to achieve higher drug concentration at the infection site. However, the use of intrastromal antibiotics is limited, as topical antibacterial agents have better penetration than antifungal agents. Bacterial and fungal keratitis have been extensively researched for intrastromal medication injections, while there is limited evidence for viral keratitis. This review emphasizes the potential of intrastromal antimicrobial injections as an alternative for managing severe refractory infectious keratitis. The technique offers direct targeting of the infection site and faster resolution in some cases compared to topical therapy. However, further research is needed to determine the safest antimicrobials options, minimal effective doses, and concentrations for various pathogens. Intrastromal injections may serve as a non-surgical treatment option in high-risk cases, with benefits including direct drug delivery and reduced epithelial toxicity. Despite promising findings, more studies are required to confirm the safety and efficacy of this approach.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, University of Medicine and Pharmacy "Carol Davila", 050474 Bucharest, Romania.
- Department of Ophthalmology, "Dr. Carol Davila" Central Military Emergency University Hospital, 010825 Bucharest, Romania.
ORCID-Profile: Sinziana Istrate
Zitieren
APA
Zemba, M., Radu, M., Istrate, S., Dumitrescu, O. M., Ionescu, M. A., Vatafu, A., & Barac, I. R. (2023). Intrastromal Injections in the Management of Infectious Keratitis. Pharmaceutics, 15(4), 1091. https://doi.org/10.3390/pharmaceutics15041091
Vancouver
Zemba M, Radu M, Istrate S, Dumitrescu OM, Ionescu MA, Vatafu A, et al. Intrastromal Injections in the Management of Infectious Keratitis. Pharmaceutics. 2023;15(4):1091. doi:10.3390/pharmaceutics15041091
BibTeX
@article{Zemba2023,
author = {Zemba, Mihail and Radu, Madalina and Istrate, Sinziana and Dumitrescu, Otilia-Maria and Ionescu, Mihai Alexandru and Vatafu, Andrei and Barac, Ileana Ramona},
title = {Intrastromal Injections in the Management of Infectious Keratitis},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {4},
pages = {1091},
doi = {10.3390/pharmaceutics15041091}
}
EUVIMED